Download PDF
Synlett 2006(20): 3484-3488  
DOI: 10.1055/s-2006-956479
LETTER
© Georg Thieme Verlag Stuttgart · New York

Efficient Synthesis of Bicyclic α-Hydroxy-α-trifluoromethyl-γ-lactams

Norio Shibata*, Hiroyuki Fujimoto, Satoshi Mizuta, Shinichi Ogawa, Yumi Ishiuchi, Shuichi Nakamura, Takeshi Toru*
Department of Applied Chemistry, Graduate School of Engineering, Nagoya Institute of Technology, Gokiso, Showa, Nagoya 466-8555, Japan
Fax: +81(52)7355442; e-Mail: nozshiba@nitech.ac.jp; e-Mail: toru@nitech.ac.jp;
Further Information

Publication History

Received 25 September 2006
Publication Date:
08 December 2006 (online)

    Permissions and Reprints All articles of this category

Abstract

A facile method for the synthesis of bicyclic 3-hydroxy-3-trifluoromethyl-γ-lactams using a variety of enamines and ethyl trifluoropyruvate with or without a catalyst was examined.

Key words

fluorine - tandem reactions - bicyclic compounds - heterocycle - green chemistry

    References and Notes

  • 1a Filler R. Kobayashi Y. Biomedicinal Aspects of Fluorine Chemistry   Elsevier Biomedical Press and Kodansya Ltd; Amsterdam: 1982. 
    Google Scholar
  • 1b Ojima I. MacCarthy JR. Welch JT. Biomedical Frontiers of Fluorine Chemistry, ACS Symposium Series   American Chemical Society; Washington DC: 1996. 
    Google Scholar
  • 1c Welch JT. Eswarakrishman S. Fluorine in Bioorganic Chemistry   Wiley; New York: 1991. 
    Google Scholar
  • 1d Filler R. Kobayashi Y. Yagupolskii LM. Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications   Elsevier; Amsterdam / New York: 1993. 
    Google Scholar
  • 2a Welch JT. Tetrahedron  1987,  43:  3123 
    CrossrefGoogle Scholar
  • 2b Kirsch P. Modern Fluoroorganic Chemistry   Wiley-VCH; Weinheim: 2004. 
    CrossrefGoogle Scholar
  • 2c Zhu SZ. Wang YL. Peng WM. Song LP. Jin GF. Curr. Org. Chem.  2002,  6:  1057 
    CrossrefGoogle Scholar
  • 2d Erian AW. J. Heterocycl. Chem.  2001,  38:  793 
    CrossrefGoogle Scholar
  • 2e Silvester MJ. Adv. Heterocycl. Chem.  1994,  59:  1 
    CrossrefGoogle Scholar
  • 2f Burger K. Adv. Heterocycl. Chem.  1994,  60:  1 
    CrossrefGoogle Scholar
  • 2g Lin P. Jiang J. Tetrahedron  2000,  56:  3635 
    CrossrefGoogle Scholar
  • For examples, see:
  • 3a Barker M. Clackers M. Copley R. Demaine DA. Humphreys D. Inglis GGA. Johnston MJ. Jones HT. Haase MV. House D. Loiseau R. Nisbet L. Pacquet F. Skone PA. Shanahan SE. Tape D. Vinader VM. Washington M. Uings I. Upton R. McLay IM. Macdonald SJF. J. Med. Chem.  2006,  49:  4216 
    CrossrefGoogle Scholar
  • 3b Betageri R. Zhang Y. Zindell RM. Kuzmich D. Kirrane TM. Bentzien J. Cardozo M. Capolino AJ. Fadra TN. Nelson RM. Paw Z. Shih D.-T. Shih C.-K. Zuvela-Jelaska L. Nabozny G. Thomson DS. Bioorg. Med. Chem. Lett.  2005,  15:  4761 
    CrossrefGoogle Scholar
  • 3c Sani M. Viani F. Binda M. Zaffaroni N. Zanda M. Lett. Org. Chem.  2005,  2:  447 
    CrossrefGoogle Scholar
  • 3d Barker M. Clackers M. Demaine DA. Humphreys D. Johnston MJ. Jones HT. Pacquet F. Pritchard JM. Salter M. Shanahan SE. Skone PA. Vinader VM. Uings I. McLay IM. Macdonald SJF. J. Med. Chem.  2005,  48:  4507 
    CrossrefGoogle Scholar
  • 3e Pinna C. Sanvito P. Bolego C. Cignarella A. Puglisi L. Eur. J. Pharmacol.  2005,  516:  71 
    CrossrefGoogle Scholar
  • 3f Molteni M. Pesenti C. Sani M. Volonterio A. Zanda M. J. Fluorine Chem.  2004,  125:  1735 
    CrossrefGoogle Scholar
  • 3g Sculptoreanu A. Yoshimura N. de Groat WC. J. Pharmacol. Exp. Ther.  2004,  310:  159 
    CrossrefGoogle Scholar
  • For examples, see:
  • 4a Labroo RB. Cohen LA. J. Org. Chem.  1990,  55:  4901 
    CrossrefGoogle Scholar
  • 4b Koguchi Y. Kohno J. Nishio M. Takahashi K. Okuda T. Ohnuki T. Komatsubara S. J. Antibiot.  2000,  53:  105 
    CrossrefGoogle Scholar
  • 4c Tang Y.-Q. Sattler I. Thiericke R. Grabley S. Feng X.-Z. Eur. J. Org. Chem.  2001,  261 
    CrossrefGoogle Scholar
  • 4d Suzuki H. Morita H. Shiro M. Kobayashi J. Tetrahedron  2004,  60:  2489 
    CrossrefGoogle Scholar
  • 4e Gorpinchenko VA. Yatsynich EA. Petrov DV. Karachurina LT. Hisamutdinova RY. Baschenko NZ. Dokichev VA. Tomilov YV. Yunusov MS. Nefedov OM. Pharm. Chem. J.  2005,  39:  289 
    CrossrefGoogle Scholar
  • 4f Meyers AI. Snyder L. J. Org. Chem.  1993,  58:  36 
    CrossrefGoogle Scholar
  • 4g Rigo B. Fasseur D. Cherepy N. Couturier D. Tetrahedron Lett.  1989,  30:  7057 
    CrossrefGoogle Scholar
  • 4h Nilsson BM. Ringdahl B. Hacksell U. J. Med. Chem.  1990,  33:  580 
    CrossrefGoogle Scholar
  • 4i Bergmann R. Gericke R. J. Med. Chem.  1990,  33:  492 
    CrossrefGoogle Scholar
  • 4j Damour D. Herman F. Labaudinière R. Pantel G. Vuilhorgne M. Mignani S. Tetrahedron  1999,  55:  10135 
    CrossrefGoogle Scholar
  • 4k Borthwick AD. Angier SJ. Crame AJ. Exall AM. Haley TM. Hart GJ. Mason AM. Pennell AMK. Weingarten GG. J. Med. Chem.  2000,  43:  4452 
    CrossrefGoogle Scholar
  • 4l Macdonald SJF. Inglis GGA. Bentley D. Dowle MD. Tetrahedron Lett.  2002,  43:  5057 
    CrossrefGoogle Scholar
  • 4m Kleinman EF. Campbell E. Giordano LA. Cohan VL. Jenkinson TH. Cheng JB. Shirley JT. Pettipher ER. Salter ED. Hibbs TA. DiCapua FM. Bordner J. J. Med. Chem.  1998,  41:  266 
    CrossrefGoogle Scholar
  • 5a Fukuzumi T. Shibata N. Sugiura M. Yasui H. Nakamura S. Toru T. Angew. Chem. Int. Ed.  2006,  45:  4973 
    CrossrefGoogle Scholar
  • 5b Shibata N. Ishimaru T. Nakamura M. Toru T. Synlett  2004,  2509 
    CrossrefGoogle Scholar
  • 5c Shibata N. Ishimaru T. Suzuki E. Kirk KL. J. Org. Chem.  2003,  68:  2494 
    CrossrefGoogle Scholar
  • 5d Shibata N. Tarui T. Doi Y. Kirk KL. Angew. Chem. Int. Ed.  2001,  40:  4461 
    CrossrefGoogle Scholar
  • 5e Shibata N. Suzuki E. Asahi T. Shiro M. J. Am. Chem. Soc.  2001,  123:  7001 
    CrossrefGoogle Scholar
  • 5f Takeuchi Y. Tarui T. Shibata N. Org. Lett.  2000,  2:  639 
    CrossrefGoogle Scholar
  • 5g Takeuchi Y. Shiragami T. Kimura K. Suzuki E. Shibata N. Org. Lett.  1999,  1:  1571 
    CrossrefGoogle Scholar
  • 6 Viswanathan N. Rawle NN. Gawad DH. J. Chem. Res., Synop.  1985,  244 
    Google Scholar
  • 7a Sviridov VD. Chkanikov ND. Galakhov MV. Shklyaev YV. Shklyaev VS. Aleksandrov BB. Gavrilov MS. Izv. Akad. Nauk. SSSR, Ser. Khim.  1990,  1405 
    Google Scholar
  • 7b Sviridov VD. Chkanikov ND. Shklyaev YV. Kolomiets AF. Fokin AV. Khim. Geterotsikl. Soedin.  1990,  1689 
    Google Scholar
  • 7c Aleksandrov BB. Gavrilov MS. Dautova RZ. Niyazov RK. Sviridov VD. Chkanikov ND. Syropyatov BY. Shklyaev VS. Sklyaev YV. Khim.-Farm. Zh.  1992,  26:  44 
    Google Scholar
  • For examples, see:
  • 8a Zhao J.-L. Liu L. Zhang H.-B. Wu Y.-C. Wang D. Chen Y. Tetrahedron Lett.  2006,  47:  2511 
    Google Scholar
  • 8b Deb I. Dadwal M. Mobin SM. Namboothiri INN. Org. Lett.  2006,  8:  1201 
    Google Scholar
  • 8c Sokolov VB. Aksinenko AY. Martynov IV. Russ. Chem. Bull.  2005,  54:  470 
    Google Scholar
  • 8d Ding R. Zhang H. Chen Y.-J. Liu L. Wang D. Li C. Synlett  2004,  555 
    Google Scholar
  • 8e Prakash GKS. Yan P. Török B. Olah GA. Synlett  2003,  527 
    Google Scholar
  • 8f Kobel’kova NM. Osipov SN. Kolomiets AF. Russ. Chem. Bull.  2002,  51:  1298 
    Google Scholar
  • 8g Golubev AS. Galakhov MV. Kolomiets AF. Fokin AV. Izv. Akad. Nauk. SSSR, Ser. Khim.  1991,  141 
    Google Scholar
  • 8h Soloshonok VA. Rozhenko AB. Butovich IA. Kukhar VP. Zh. Org. Khim.  1990,  26:  2051 
    Google Scholar
  • 8i Soloshonok VA. Kukhar VP. Zh. Org. Khim.  1990,  26:  419 
    Google Scholar
  • 8j Golubev AS. Kolomiets AF. Fokin AV. Izv. Akad. Nauk. SSSR, Ser. Khim.  1989,  2369 
    Google Scholar
  • For examples, see:
  • 9a Suri JT. Mitsumori S. Albertshofer K. Tanaka F. Barbas CF. J. Org. Chem.  2006,  71:  3822 
    CrossrefGoogle Scholar
  • 9b Lyle MPA. Draper ND. Wilson PD. Org. Lett.  2005,  7:  901 
    CrossrefGoogle Scholar
  • 9c Du M. Lu S.-F. Fang T. Xu J. J. Org. Chem.  2005,  70:  3712 
    CrossrefGoogle Scholar
  • 9d Mikami K. Kakuno H. Aikawa K. Angew. Chem. Int. Ed.  2005,  44:  7257 
    CrossrefGoogle Scholar
  • 9e Zhuang W. Poulsen TB. Jørgensen KA. Org. Biomol. Chem.  2005,  3:  3284 
    CrossrefGoogle Scholar
  • 9f Török B. Abid M. London G. Esquibel J. Török M. Mhadgut SC. Yan P. Prakash GKS. Angew. Chem. Int. Ed.  2005,  44:  3086 
    CrossrefGoogle Scholar
  • 9g Mikami K. Aikawa K. Kainuma S. Kawakami Y. Saito T. Sayo N. Kumobayashi H. Tetrahedron: Asymmetry  2004,  15:  3885 
    CrossrefGoogle Scholar
  • 9h Lu S.-F. Du D.-M. Zhang S.-W. Xu J. Tetrahedron: Asymmetry  2004,  15:  3433 
    CrossrefGoogle Scholar
  • 9i Gathergood N. Juhl K. Poulsen TB. Thordrup K. Jørgensen KA. Org. Biomol. Chem.  2004,  2:  1077 
    CrossrefGoogle Scholar
  • 9j Bøgevig A. Gothelf KV. Jørgensen KA. Chem. Eur. J.  2002,  8:  5652 
    CrossrefGoogle Scholar
  • 9k Corma A. García H. Moussaif A. Sabater MJ. Zniber R. Redouane A. Chem. Commun.  2002,  1058 
    CrossrefGoogle Scholar
  • 9l Bøgevig A. Kumaragurubaran N. Jørgensen KA. Chem. Commun.  2002,  620 
    CrossrefGoogle Scholar
  • 9m Zhuang W. Gathergood N. Hazell RG. Jørgensen KA. J. Org. Chem.  2001,  66:  1009 
    CrossrefGoogle Scholar
  • 9n Gathergood N. Zhuang W. Jørgensen KA. J. Am. Chem. Soc.  2000,  122:  12517 
    CrossrefGoogle Scholar
  • 10a Paleček J. Paleta O. Synthesis  2004,  521 
    Article in Thieme ConnectGoogle Scholar
  • 10b Volochnyuk DM. Kostyuk AN. Sibgatulin DA. Petrenko AE. Synthesis  2004,  2545 
    Article in Thieme ConnectGoogle Scholar
  • 13 Furukawa Y, and Kishimoto E. inventors; Jpn. Kokai Tokkyo Koho JP  226351A. 
  • 14 Shipchandler MT. Mitscher LA. J. Heterocycl. Chem.  1971,  8:  695 
    CrossrefGoogle Scholar
11

Although a literature survey on SciFinder® reveals the types of compounds 1 as being registered, surprisingly, neither references nor the synthetic information on them is available.

12

Compound 1a: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 2.02-2.18 (m, 2 H), 2.26-2.66 (m, 4 H), 4.37 (br s, 1 H), 4.65 (d, J = 15.8 Hz, 1 H), 4.89 (d, J = 15.8 Hz, 1 H), 7.15-7.20 (m, 2 H), 7.31-7.42 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.1 (s, 3 F). IR (KBr): 3128, 1763, 1632, 1601, 1413, 1359, 1263, 1183, 1158, 1075, 1026, 960, 945, 737, 712, 568, 499 cm-1. MS (EI): m/z = 325 [M+].
Compound 1b: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 2.09-2.22 (m, 2 H), 2.36-2.68 (m, 4 H), 4.48 (br s, 1 H), 7.19-7.25 (m, 2 H), 7.45-7.56 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.4 (s, 3 F). IR (KBr): 3424, 1767, 1651, 1613, 1496, 1399, 1255, 1191, 1086, 1015, 849, 744, 715, 552 cm-1. MS (EI): m/z = 311 [M+].
Compound 1c: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.75-1.97 (m, 4 H), 2.10-2.35 (m, 1 H), 2.34-2.50 (m, 1 H), 2.86-3.04 (m, 2 H), 3.62 (ddd, J = 14.0, 7.6, 5.6 Hz, 1 H), 3.87 (dt, J = 14.0, 6.2 Hz, 1 H), 4.34 (d, J = 4.2 Hz, 1 H), 7.08-7.14 (m, 2 H), 7.27-7.32 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.0 (s, 3 F). IR (KBr): 3250, 2960, 1764, 1638, 1593, 1458, 1433, 1366, 1336, 1277, 1256, 1184, 1161, 1072, 985, 946, 841, 755, 708, 562, 499 cm-1. MS (EI): m/z = 339 [M+].
Compound 1d: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.05 (s, 3 H), 1.07 (s, 3 H), 2.24 (d, J = 16.6 Hz, 1 H), 2.35 (s, 2 H), 2.38 (d, J = 16.6 Hz, 1 H), 4.26 (br s, 1 H), 4.66 (d, J = 16.0 Hz, 1 H), 4.89 (d, J = 16.0 Hz, 1 H), 7.13-7.18 (m, 2 H), 7.31-7.41 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.0 (s, 3 F). IR (KBr): 3201, 2961, 1756, 1625, 1599, 1421, 1267, 1191, 1173, 1062, 956, 701 cm-1. MS (EI): m/z = 353 [M+].
Compound 1e: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.12 (s, 3 H), 1.14 (s, 3 H), 2.29 (d, J = 18.6 Hz, 1 H), 2.23 (d, J = 16.4 Hz, 1 H), 2.41 (d, J = 18.6 Hz, 1 H), 2.45 (d, J = 16.4 Hz, 1 H), 4.44 (br s, 1 H), 7.17-7.22 (m, 2 H), 7.47-7.53 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.0 (s, 3 F). IR (KBr): 3398, 3222, 2962, 1766, 1647, 1615, 1496, 1400, 1244, 1192, 1163, 1074, 1048, 897, 742, 715, 571, 505, 449 cm-1. MS (EI): m/z = 339 [M+].
Compound 1f: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 0.85 (s, 3 H), 0.95 (s, 3 H), 1.67 (d, J = 18.2 Hz, 1 H), 1.80 (d, J = 18.2 Hz, 1 H), 2.10 (d, J = 16.4 Hz, 1 H), 2.22 (d, J = 16.4 Hz, 1 H), 2.80-3.03 (m, 2 H), 3.60 (ddd, J = 14.0, 7.8, 5.6 Hz, 1 H), 3.89 (dt, J = 14.2, 6.0 Hz, 1 H), 4.28 (br s, 1 H), 7.10-7.14 (m, 2 H), 7.31-7.34 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -77.8 (s, 3 F). IR (KBr): 3200, 2962, 1755, 1642, 1605, 1422, 1263, 1189, 1167, 1068, 701, 497 cm-1. MS (EI): m/z = 367 [M+].
Compound 5g: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.31 (t, J = 7.2 Hz, 3 H), 1.75-1.93 (m, 2 H), 2.27-2.37 (m, 2 H), 2.47-2.62 (m, 2 H), 4.17-4.34 (m, 2 H), 5.76 (d, J = 6.4 Hz, 1 H), 6.06 (s, 1 H), 7.21-7.42 (m, 10 H), 7.69 (d, J = 6.4 Hz, 1 H). 19F NMR (188 MHz, CDCl3): δ = -76.1 (s, 3 F). IR (KBr): 3321, 2953, 1747, 1565, 1432, 1373, 1281, 1193, 1034, 991, 946, 744, 704, 550 cm-1. MS (EI): m/z = 447 [M+].
Compound 1g: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.86-2.06 (m, 3 H), 2.18-2.54 (m, 3 H), 4.20 (br s, 1 H), 6.81 (s, 1 H), 7.15-7.20 (m, 4 H), 7.33-7.45 (m, 6 H). 19F NMR (188 MHz, CDCl3): δ = -78.1 (s, 3 F). IR (KBr): 3400, 3064, 3033, 2954, 1759, 1647, 1603, 1243, 1191, 1165, 1076, 1013, 741, 715, 700, 612, 512, 418 cm-1. MS (EI): m/z = 401 [M+].
Compound 1h: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 0.93 (s, 3 H), 1.01 (s, 3 H), 1.89 (d, J = 18.2 Hz, 1 H), 2.09 (d, J = 18.2 Hz, 1 H), 2.16 (d, J = 16.4 Hz, 1 H), 2.31 (d, J = 16.4 Hz, 1 H), 4.29 (br s, 1 H), 6.83 (s, 1 H), 7.17-7.21 (m, 4 H), 7.34-7.41 (m, 6 H). 19F NMR (188 MHz, CDCl3): δ = -77.9 (s, 3 F). IR (KBr): 3390, 2962, 1765, 1646, 1600, 1424, 1405, 1356, 1266, 1225, 1193, 1161, 1078, 1067, 904, 743, 702, 567, 447 cm-1. MS (EI): m/z = 429 [M+].
Compound 1i: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 2.13-2.24 (m, 2 H), 2.32-2.62 (m, 4 H), 4.41 (br s, 1 H), 4.68 (d, J = 16.4 Hz, 1 H), 5.09 (d, J = 16.4 Hz, 1 H), 7.64 (s, 2 H), 7.87 (s, 1 H). 19F NMR (188 MHz, CDCl3): δ = -63.0 (s, 6 F), -78.3 (s, 3 F). IR (KBr): 3545, 1764, 1645, 1612, 1408, 1353, 1281, 1184, 1133, 1081, 957, 708, 684 cm-1. MS (EI): m/z = 461 [M+].
Compound 1j: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 2.02-2.16 (m, 2 H), 2.29-2.59 (m, 4 H), 4.39 (br s, 1 H), 4.88 (d, J = 16.8 Hz, 1 H), 5.12 (d, J = 16.8 Hz, 1 H), 7.09 (d, J = 7.6 Hz, 1 H), 7.44 (t, J = 7.6 Hz, 1 H), 7.56 (t, J = 7.6 Hz, 1 H), 7.72 (t, J = 7.6 Hz, 1 H). 19F NMR (188 MHz, CDCl3): δ = -60.1 (s, 3 F), -78.0 (s, 3 F). IR (KBr): 3126, 2813, 1760, 1645, 1612, 1409, 1319, 1263, 1157, 1110, 1080, 1039, 967, 946, 878, 770, 709, 657, 426 cm-1. MS (EI): m/z = 393 [M+].
Compound 1k: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.79-1.98 (m, 4 H), 2.63-2.71 (m, 4 H), 4.65 (d, J = 16.2 Hz, 1 H), 4.97 (d, J = 16.2 Hz, 1 H), 5.99 (s, 1 H), 7.13-7.17 (m, 2 H), 7.29-7.40 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.1 (s, 3 F). IR (KBr): 3384, 3011, 2948, 2883, 1761, 1590, 1403, 1320, 1259, 1207, 1171, 1039, 944, 743, 710, 627, 525, 463 cm-1. MS (EI): m/z = 339 [M+].
Compound 1l: brown oil. 1H NMR (200 MHz, CDCl3): δ = 2.23 (s, 3 H), 4.79 (d, J = 16.0 Hz, 1 H), 4.87 (d, J = 16.0 Hz, 1 H), 7.10-7.17 (m, 2 H), 7.30-7.36 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.6 (s, 3 F). IR (neat): 3341, 2220, 1748, 1633, 1402, 1352, 1267, 1181, 1139, 1083, 1032, 953, 742, 716, 614, 557 cm-1. MS (EI): m/z = 296 [M+].
Compound 4: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.80 (br s, 1 H), 4.65 (d, J = 15.8 Hz, 1 H), 5.10 (d, J = 15.8 Hz, 1 H), 5.65 (br s, 1 H), 6.34 (d, J = 7.6 Hz, 1 H), 6.65 (d, J = 8.4 Hz, 1 H) 7.15-7.40 (m, 6 H). 19F NMR (188 MHz, CDCl3): δ = -78.1 (s, 3 F). IR (KBr): 3592, 3471, 3338, 3239, 1721, 1618, 1471, 1388, 1352, 1281, 1174, 1123, 1038, 948, 788, 702 cm-1. MS (EI): m/z = 323 [M+].
Compound 5m: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.34 (t, J = 7.2 Hz, 3 H), 2.43-2.48 (m, 1 H), 2.58-2.65 (m, 2 H), 4.25-4.38 (m, 2 H), 4.51 (d, J = 6.0 Hz, 2 H), 7.20-7.25 (m, 2 H), 7.31-7.43 (m, 3 H), 8.01 (br d, 1 H), 9.76 (s, 1 H). 19F NMR (188 MHz, CDCl3): δ = -78.7 (s, 3 F). IR (KBr): 3375, 2986, 2715, 1759, 1648, 1558, 1453, 1433, 1341, 1240, 1192, 1158, 1038, 970, 737, 665, 461 cm-1. MS (EI): m/z = 357 [M+].